(PGJ) Invesco Golden Dragon China - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46137V5710
PGJ: Stocks, Equities, Chinese, Companies
The Invesco Golden Dragon China ETF (PGJ) is an exchange-traded fund that focuses on U.S. exchange-listed companies with ties to China, specifically those headquartered or incorporated in the Peoples Republic of China. By investing at least 90% of its assets in the underlying indexs securities, the fund provides a targeted exposure to Chinese companies listed in the U.S.
The funds non-diversified nature means it may be more susceptible to market fluctuations related to the Chinese economy and geopolitical tensions between China and the U.S. However, this also allows for a more concentrated investment in a specific segment of the market, potentially leading to higher returns if the sector performs well.
From a technical standpoint, the recent price action of PGJ indicates a potential bullish trend. The last price of $29.34 is above both the 50-day SMA of $28.47 and the 200-day SMA of $26.37, suggesting a positive momentum. The 20-day SMA of $27.27 further supports this, as the price has bounced back from this level. The ATR of 0.90, or 3.08% of the last price, indicates a moderate level of volatility, which is expected given the funds focus on a specific and potentially volatile market segment.
Considering the current technical and fundamental data, a forecast for PGJ could be constructed. With the current price above key moving averages and a relatively stable volatility profile, the fund is poised for potential growth if the underlying Chinese companies continue to perform well. However, the AUM of $142.66M suggests that the fund is not overly large, which could impact liquidity. If the 52-week high of $32.49 is retested, PGJ could potentially see a further increase, driven by the underlying indexs performance. Conversely, a decline below the 200-day SMA could signal a downturn. Therefore, a likely forecast is that PGJ will continue to be influenced by the performance of Chinese companies listed in the U.S., with a potential target near the 52-week high if the current trend persists.
Additional Sources for PGJ ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
PGJ ETF Overview
Market Cap in USD | 142m |
Category | China Region |
TER | 0.70% |
IPO / Inception | 2004-12-09 |
PGJ ETF Ratings
Growth Rating | -22.2 |
Fundamental | - |
Dividend Rating | 59.4 |
Rel. Strength | 7.66 |
Analysts | - |
Fair Price Momentum | 26.34 USD |
Fair Price DCF | - |
PGJ Dividends
Dividend Yield 12m | 4.75% |
Yield on Cost 5y | 3.04% |
Annual Growth 5y | 44.54% |
Payout Consistency | 78.1% |
Payout Ratio | % |
PGJ Growth Ratios
Growth Correlation 3m | -14.1% |
Growth Correlation 12m | 70.5% |
Growth Correlation 5y | -68.8% |
CAGR 5y | -8.04% |
CAGR/Max DD 5y | -0.10 |
Sharpe Ratio 12m | -0.20 |
Alpha | 10.26 |
Beta | 0.727 |
Volatility | 29.23% |
Current Volume | 23.3k |
Average Volume 20d | 25.1k |
As of June 16, 2025, the stock is trading at USD 28.18 with a total of 23,274 shares traded.
Over the past week, the price has changed by -0.70%, over one month by -2.63%, over three months by -7.36% and over the past year by +19.74%.
Neither. Based on ValueRay´s Analyses, Invesco Golden Dragon China is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -22.21 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PGJ is around 26.34 USD . This means that PGJ is currently overvalued and has a potential downside of -6.53%.
Invesco Golden Dragon China has no consensus analysts rating.
According to our own proprietary Forecast Model, PGJ Invesco Golden Dragon China will be worth about 29.6 in June 2026. The stock is currently trading at 28.18. This means that the stock has a potential upside of +5.04%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 29.6 | 5% |